APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneOperatingExpenses01Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentRevenue01Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentRevenue02Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentRevenue03Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentRevenue04Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentResults01Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentResults02Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentResults03Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentResults04Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentAssets01Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentAssets02Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentAssets03Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentAssets04Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2020-06-30in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentLiabilities02Member APOLLOHOSP2020-06-30in-bse-fin:OneReportableSegmentLiabilities02Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentLiabilities03Member APOLLOHOSP2020-06-30in-bse-fin:OneReportableSegmentLiabilities03Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneReportableSegmentLiabilities04Member APOLLOHOSP2020-06-30in-bse-fin:OneReportableSegmentLiabilities04Member APOLLOHOSP2020-04-012020-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares APOLLOHOSP 2020-04-01 2021-03-31 2020-09-01 INR Lakhs First quarter Multi segment 2020-04-01 2020-06-30 Unaudited Consolidated 21715000000.00 77200000.00 21792200000.00 2768100000.00 10732500000.00 -1325300000.00 4486400000.00 1273900000.00 1601800000.00 4698500000.00 24235900000.00 -2443700000.00 0.00 -2443700000.00 82800000.00 -490400000.00 -407600000.00 0.00 -2036100000.00 0.00 0.00 0.00 -226300000.00 -2262400000.00 -15600000.00 -2278000000.00 -2081900000.00 -180500000.00 -15600000.00 0.00 695600000.00 5 -14.97 -14.97 0.00 0.00 -14.97 -14.97 Pursuant to the Scheme of Arrangement (‘the Scheme’), duly sanctioned by the National Company Law Tribunal (NCLT) vide order dated August 3, 2020, with effect from April 1, 2019 (‘Appointed date’), the front-end retail pharmacy included in the standalone pharmacy segment is transferred to Apollo Pharmacies Limited (“APL”), a wholly owned subsidiary of Apollo Medicals Private Limited (AMPL) for an overall cash consideration of Rs.52,780 lakhs. In accordance with Section 230 of the Companies Act, the Company filed the NCLT order with the Ministry of Company Affairs (Registrar of Companies) on September 1, 2020. Consequent to the filing, the Scheme became effective from September 1, 2020 (‘effective date’). nAs per the Scheme, the Group shall account the transfer of assets and liabilities pertaining to the front-end retail pharmacy upon the Scheme becoming effective. Consequently, no impact of the aforesaid transfer have been given effect in the above results. The front-end retail pharmacy does not constitute a separate component under Ind AS 105 Non-current Assets Held for Sale and Discontinued Operations and represents a portion in the standalone pharmacy segment. Consequently, the transfer of front-end retail pharmacy has not been presented as a discontinued operations. nThe Group holds 25.5% of the equity shares in AMPL as on the effective date. nThe Board of Directors approved at its meeting held on February 13, 2020 the proposal for merger of the following wholly owned subsidiary companies with the Company. na.tApollo Home Healthcare (India) Limited and b.tWestern Hospitals Corporation Private Limited nThe Parent is in the process of submitting the requisite applications with NCLT seeking dispensing of convening shareholders/creditors meetings of the Company. nThe Management has considered the possible effects if any that may result from the pandemic relating to COVID-19 on recoverability of receivables, Property, plant & equipment including Capital work in progress and certain investments. The Group has considered internal and external information up to the date of approval of these financial results. Based on the current indicators of future economic conditions, the Group expects to recover the carrying amount of these assets. The actual outcome of these assumptions and estimates may vary in future due to the impact of the pandemic. The Group will continue to monitor any material changes to future economic conditions and the consequent impact on its business, if any, and any significant impact of these changes would be recognized in the financial results as and when these material changes to economic conditions arise. n6.tThe proceedings initiated against Imperial Hospitals and Research Centre Limited, a subsidiary company, by the Government of Karnataka alleging, non-compliance of certain conditions associated with the allotment of land, has been stayed by the Honourable High Court of Karnataka on April 27, 2018. Based on legal opinion, the management is of the opinion that it has adequate grounds to demonstrate compliance with applicable conditions and therefore the proceedings are not sustainable. There have been no further developments during this quarter. Other Expenses 4698500000.00 Healthcare services 7952700000.00 Pharmacy 12791500000.00 clinics 1024300000.00 others 10000000.00 21778500000.00 63500000.00 21715000000.00 Healthcare services -1813300000.00 Pharmacy 819600000.00 clinics -245300000.00 others -8000000.00 -1247000000.00 1273900000.00 -77200000.00 -2443700000.00 Healthcare services 76076900000.00 Pharmacy 21096000000.00 clinics 8089800000.00 others 469900000.00 105732600000.00 7313600000.00 113046200000.00 Healthcare services 23760200000.00 Pharmacy 11637000000.00 clinics 6282900000.00 others 187500000.00 41867600000.00 39986600000.00 81854200000.00